These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1037 related articles for article (PubMed ID: 30078711)

  • 1. Deep Profiling of Mouse Splenic Architecture with CODEX Multiplexed Imaging.
    Goltsev Y; Samusik N; Kennedy-Darling J; Bhate S; Hale M; Vazquez G; Black S; Nolan GP
    Cell; 2018 Aug; 174(4):968-981.e15. PubMed ID: 30078711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical efficacy of buprenorphine to minimize distress in MRL/lpr mice.
    Swenson J; Olgun S; Radjavi A; Kaur T; Reilly CM
    Eur J Pharmacol; 2007 Jul; 567(1-2):67-76. PubMed ID: 17490635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CODEX multiplexed tissue imaging with DNA-conjugated antibodies.
    Black S; Phillips D; Hickey JW; Kennedy-Darling J; Venkataraaman VG; Samusik N; Goltsev Y; Schürch CM; Nolan GP
    Nat Protoc; 2021 Aug; 16(8):3802-3835. PubMed ID: 34215862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic norepinephrine is decreased in MRL-lpr/lpr mice.
    Breneman SM; Moynihan JA; Grota LJ; Felten DL; Felten SY
    Brain Behav Immun; 1993 Jun; 7(2):135-43. PubMed ID: 8347895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurodegeneration in autoimmune MRL-lpr mice as revealed by Fluoro Jade B staining.
    Ballok DA; Millward JM; Sakic B
    Brain Res; 2003 Feb; 964(2):200-10. PubMed ID: 12576180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice].
    Wang ZH; Zhang W; Zhang YQ; Pang CY; Wang YF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):771-776. PubMed ID: 27752154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
    Ashman RF; Singh N; Lenert PS
    Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody therapy that targets phospholipid-binding protein delays lupus activity in MRL/lpr mice.
    Mihaylova N; Bradyanova S; Chipinski P; Chausheva S; Kyurkchiev D; Tchorbanov AI
    Scand J Immunol; 2020 Sep; 92(3):e12915. PubMed ID: 32533866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
    Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
    Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential tissue expression of erythroblast macrophage protein in a MRL/lpr mouse model of lupus.
    Fan H; Li N; Fan P; Hu X; Liang K; Zhang S; Cheng X; Wu Y
    Lupus; 2019 Jun; 28(7):843-853. PubMed ID: 31132907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice.
    Zhang XK; Gallant S; Molano I; Moussa OM; Ruiz P; Spyropoulos DD; Watson DK; Gilkeson G
    J Immunol; 2004 Nov; 173(10):6481-9. PubMed ID: 15528390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone treatment inhibits the differentiation of B lymphocytes into plasma cells in MRL/MpSlac-lpr mice.
    Yan SX; Deng XM; Wang QT; Sun XJ; Wei W
    Acta Pharmacol Sin; 2015 Nov; 36(11):1367-76. PubMed ID: 26456588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H; Hirata D; Kamimura T; Sato H; Iwamoto M; Yoshio T; Masuyama J; Fujimura A; Kobayashi E; Kano S; Minota S
    J Rheumatol; 2002 Apr; 29(4):707-16. PubMed ID: 11950011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rel B-modified dendritic cells possess tolerogenic phenotype and functions on lupus splenic lymphocytes in vitro.
    Wu H; Lo Y; Chan A; Law KS; Mok MY
    Immunology; 2016 Sep; 149(1):48-61. PubMed ID: 27278094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nonmyeloablative unrelated fetal and neonatal murine peripheral blood mononuclear cell infusion on MRL/lpr mice.
    Chuan W; Wu-qing W; Zhu-wen Y; Zuo L
    Lupus; 2014 Sep; 23(10):994-1005. PubMed ID: 24756437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice.
    Komori H; Furukawa H; Mori S; Ito MR; Terada M; Zhang MC; Ishii N; Sakuma N; Nose M; Ono M
    J Immunol; 2006 Jan; 176(1):395-400. PubMed ID: 16365433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition.
    Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N
    J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A benzenediamine derivative fc-99 attenuates lupus-like syndrome in MRL/lpr mice related to suppression of pDC activation.
    Ji J; Fan H; Li F; Li X; Dong G; Gong W; Song Y; Liu F; Hua C; Tan R; Dou H; Hou Y
    Immunol Lett; 2015 Dec; 168(2):355-65. PubMed ID: 26545567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected development of autoimmunity in BAFF-R-mutant MRL-lpr mice.
    Ju ZL; Shi GY; Zuo JX; Zhang JW;
    Immunology; 2007 Feb; 120(2):281-9. PubMed ID: 17073941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.